Venture capital
MBX Capital
MBX Capital is a venture capital firm focused on early-stage life sciences and health companies, which it describes as Deep Health.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is MBX Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds MBX Capital joined, from press and the firm’s own posts.
Every round MBX Capital joined
Round sizes, MBX Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company MBX Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet MBX Capital
Events where MBX Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
MBX Capital is based in Tuxedo Park, United States.
45 fund vehicles are on public registers (SEC adviser filings), including MBX CAPITAL III, LP, MBX CAPITAL II, LP and FRX SELECT I, LP.
Sectors: Life sciences. From the firm’s own website.
MBX Capital lists 29 portfolio companies on its website, including AmacaThera, Ancilia Bio, Arine, Atlas Health and Attivare Therapeutics.
Firms whose websites list some of the same companies include Metaplanet, Amboy Street Ventures and Hummingbird VC.
Know before MBX Capital’s next round is announced.
PRO tracks MBX Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.